The largest database of trusted experimental protocols
> Procedures > Diagnostic Procedure > 2D Echocardiography

2D Echocardiography

2D Echocardiography is a non-invasive imaging technique that uses sound waves to create real-time, two-dimensional images of the heart's structure and function.
It allows for the evaluation of cardiac anatomy, valve function, and the assessment of heart wall motion and pumping ability. 2D Echocardiography is a widely used diagnostic tool in cardiiology, providing valuable information for the detection and management of various heart conditions.
It is a safe, radiation-free procedure that can be performed at the bedside or in a clinical setting. 2D Echocardiography has become an indispensable tool in cardiovascular care, enabling clinicians to make informed decisions and deliver personalized treatment plans for their patients.

Most cited protocols related to «2D Echocardiography»

MuRF1 Tg+ and littermate wild type controls (50% male/50% female) at 10-12 weeks of age underwent trans-aortic constriction (TAC) to induce cardiac hypertrophy as previously described 7 (link). No significant differences between genders were noted throughout the study. MuRF1 Tg+ and wild type controls underwent conscious echocardiographic analysis at baseline (prior to TAC) and then weekly for 4 weeks following the TAC procedure (10 mice/group). Additional mice (5/group) underwent conscious echocardiographic analysis at baseline and subsequently every 2 months for 18 months. M-mode and two-dimensional echocardiography was performed using the Vevo 660 ultrasound system as previously described 7 (link). Hearts were dissected from the body and perfused with 4% paraformaldehyde. Paraffin sections were stained with hematoxylin and eosin, Masson's trichrome, or fluorescently labeled lectin as previously described 7 (link). For cross-sectional area analysis of cardiomyocytes, TRITC conjugated lectin (Triticum vulgaris) staining was performed and measured as previously described and examined by fluorescence microscopy 7 (link).
Additional materials and methods may be found in the online supplement.
Publication 2009
2D Echocardiography Aorta Aortic Valve Stenosis Cardiac Hypertrophy Consciousness Constriction Dietary Supplements Echocardiography Eosin Females Heart Human Body Lectin Males Mice, Laboratory Microscopy, Fluorescence Myocytes, Cardiac Paraffin paraform Sex Characteristics tetramethylrhodamine isothiocyanate TRIM63 protein, human Triticum Ultrasonography
For speckle tracking analysis, apical four- and two-chamber views images were obtained using conventional two-dimensional gray scale echocardiography, during breath hold with a stable ECG recording. Particular attention was given to obtain an adequate gray scale image, allowing reliable delineation of myocardial tissue and extracardiac structures. Three consecutive heart cycles were recorded and averaged. The frame rate was set between 60 and 80 frames per second. These settings are recommended to combine temporal resolution with adequate spatial definition, and to enhance the feasibility of the frame-to-frame tracking technique[13 (link)].
Recordings were processed using an acoustic-tracking software (Echo Pac, GE, USA), allowing off-line semi-automated analysis of speckle-based strain[14 (link),15 (link)] (Figure 1). Briefly, LA endocardial surface is manually traced in both four- and two-chamber views by a point-and-click approach. An epicardial surface tracing is then automatically generated by the system, thus creating a region of interest (ROI). After manual adjustment of ROI width and shape, the software divides the ROI into 6 segments, and the resulting tracking quality for each segment is automatically scored as either acceptable or non-acceptable, with the possibility of further manual correction. Segments in which no adequate image quality can be obtained are rejected by the software and excluded from the analysis. Lastly, the software generates strain curves for each atrial segment. In subjects with adequate image quality, a total of 12 segments were then analyzed. To trace the ROI in the discontinuity of LA wall corresponding to pulmonary veins and LA appendage, the direction of LA endocardial and epicardial surfaces at the junction with these structures was extrapolated. Peak atrial longitudinal strain (PALS) was calculated by averaging values observed in all LA segments (global PALS), and by separately averaging values observed in 4- and 2-chamber views (4- and 2-chamber average PALS) (Figure 2). The time to peak longitudinal strain (TPLS) was also measured as the average of all 12 segments (global TPLS) and by separately averaging values observed in the two apical views (4- and 2-chamber average TPLS). In patients in whom some segments were excluded because of the impossibility of achieving adequate tracking, PALS and TPLS were calculated by averaging values measured in the remaining segments.
Reproducibility of PALS and TPLS measurements was assessed in 20 randomly selected subjects. Intra and inter-observer variability coefficients were calculated using images independently recorded in two different occasions by the same investigator or by two different observers.
Publication 2009
2D Echocardiography Acoustics Attention ECHO protocol Endocardium Heart Heart Atrium Myocardium Patients Reading Frames Strains Veins, Pulmonary
Echocardiographic examinations were performed on commercially available ultrasound systems (Vivid S5, Vivid i, Vivid 7, and Vivid E9 GE Healthcare Vingmed, Trondheim, Norway and ie33, Philips, Eindhoven, the Netherlands) according to the guidelines of the American Society of Echocardiography.21 (link) Images were obtained in left lateral decubitus for parasternal and apical views and supine position for subxyphoidal views using 1.5 to 4.0 MHz phased‐array transducers. The comprehensive examination included standard 2D echocardiography for anatomic imaging and Doppler echocardiography for assessment of velocities. Doppler measurements were carried out over 3 heart cycles during passive expiration. All examinations were digitally stored in a Picture Archiving and Communication System (PACS) with accessibility for offline analysis on workstations (Centricity, GE Healthcare Vingmed, Trondheim, Norway).
Noninvasive assessment of pulmonary artery systolic pressures (sPAP) was achieved by measurement of right ventricular systolic pressure (RVSP) and adding RAP. RVSP was derived from the peak systolic velocity of the tricuspid regurgitation obtained with continuous‐wave (CW) Doppler using the modified Bernoulli equation: ΔP=4×Vmax2. RAP was estimated by the diameter of the inferior vena cava and its variability during inspiration as described before.9 (link),21 (link)–22 (link)Offline reassessment of CW Doppler spectral envelopes, as well as inferior vena cava diameter and respiratory behavior, was conducted in n=258 examination for clarification of misdiagnosis of PH by 2 independent, experienced examiners blinded to invasive data.
Publication 2014
2D Echocardiography Echocardiography Echocardiography, Doppler Heart Inhalation Physical Examination Pulmonary Artery Respiratory Rate Systole Systolic Pressure Transducers Tricuspid Valve Insufficiency Ultrasonography Vena Cavas, Inferior Ventricles, Right
From January 2018 to June 2018, 33 consecutive NOHCM patients who met the inclusion criteria were enrolled [17 (link)]. The inclusion criteria included: (1) CMR demonstrated LV hypertrophy (maximal wall thickness ≥ 15 mm in an adult or ≥ 13 mm in an adult with relatives with HCM) in the absence of other diseases that could cause the LV hypertrophy [17 (link)], (2) left ventricular outflow tract (LVOT) gradient ≤30 mmHg on 2-dimensional echocardiography at rest or ≤ 50 mmHg during or immediately following exercise [17 (link)], (3) normal size of both ventricles and atria [18 (link)] and LV ejection fraction (EF) > 50%. Exclusion criteria included: (1) history of coronary artery disease, myocardial infarction or myocarditis, (2) history of septal myectomy or alcoholic septal ablation, (3) history of atrial fibrillation or atrial fibrillation at the time of CMR, (4) known contraindications to CMR imaging. Twenty-eight healthy subjects were selected as control group. This control group consisted of 13 females and 15 males with no history of cardiovascular disease, normal physical examination, normal electrodcardiogram (ECG) and echocardiography. Written informed consent was obtained from all study participants. This study was approved by our local institutional review boards.
Publication 2020
2D Echocardiography Adult Alcoholics Atrial Fibrillation Cardiovascular Diseases Coronary Artery Disease Echocardiography Ethics Committees, Research Females Healthy Volunteers Heart Atrium Heart Ventricle Left Ventricular Hypertrophy Males Myocardial Infarction Myocarditis Patients Physical Examination
All echocardiographic studies1 were performed by a board‐certified veterinary cardiologist (L.C.V or J.A.S.) or a cardiology resident under the direct supervision of a board‐certified veterinary cardiologist and all raw data were captured digitally for offline analysis at a digital workstation.2 Dogs were manually restrained in right and left lateral recumbency. Use of sedation and supplemental oxygen was permitted if deemed necessary by the attending clinician. Conventional imaging planes21 were utilized with continuous ECG monitoring. Care was taken to align the TR jet as parallel as possible to the plane of the ultrasound interrogation cursor. Care was also taken to optimize visualization of the main and right pulmonary arteries via the 2D echocardiographic view from a right parasternal short axis basilar position. Quantification of a pulmonary valve insufficiency jet to estimate mean and diastolic pulmonary artery pressures was not performed for the purposes of this study.
Publication 2016
2D Echocardiography Canis familiaris Cardiologists Cardiovascular System Echocardiography Epistropheus Oxygen Pressure, Diastolic Pulmonary Artery Pulmonary Valve Insufficiency Sedatives Supervision Ultrasonography

Most recents protocols related to «2D Echocardiography»

Baseline clinical information, including age, sex, body mass index (BMI), disease duration, comorbidities, medication, and LV ejection fraction (LVEF) obtained from 2D echocardiography [27 (link)], from each subject was recorded. Participants had blood sampling before the baseline CMR-LGE imaging study and then underwent a graded cardiopulmonary exercise test (CPET). The physical component score (PCS) and mental component score (MCS) of the Medical Outcomes Study Short Form-36 health survey (SF-36) for quality of life (QoL) were assessed before initiating each CPET. The follow-up CMR-LGE, CPET, and blood samplings were performed within 1 week after completing 36 sessions of HIIT. Haematocrit and b-type natriuretic peptide (BNP) were also measured before and after HIIT. After completing the above study, the remaining blood sample was centrifuged at 2500 rpm for 5 min at room temperature for serum preparation. A graphic depicting the experimental procedure is shown in Additional file 1.
Publication 2023
2D Echocardiography BLOOD Cardiopulmonary Exercise Test Index, Body Mass Mental Health Nesiritide Pharmaceutical Preparations Phlebotomy Physical Examination Serum Volumes, Packed Erythrocyte
Two-dimensional M-mode transthoracic echocardiography was performed for all patients by the EPIQ 7°C ultrasound system (Philips, Best, The Netherlands) before coronary intervention. Left ventricular (LV) dimensions, and septal and posterior wall thicknesses obtained at the parasternal long-axis image M-mode echocardiography and LV ejection fraction was calculated according to the modified Simpson’s method [8 (link)].
Publication 2023
2D Echocardiography Echocardiography, M-Mode Epistropheus Heart Left Ventricles Patients Ultrasonography Ventricular Ejection Fraction
In this study, a total of 500 patients who underwent cardiovascular MRI imaging between 2015 November and 2018 December were retrospectively reviewed. Patient demographic data were obtained from the hospital information system. All the individuals had transthoracic two-dimensional echocardiography before the cardiovascular MRI examination. The echocardiography and cardiac catheter findings of the individuals were used only to determine the primary diagnosis and guide to the cardiovascular MRI.
All patients were evaluated for claustrophobia and the presence of contraindications, including MRI non-compatible implants, pacemakers, and excluded from the examination.
Publication 2023
2D Echocardiography Cardiac Catheters Cardiovascular System Claustrophobia Diagnosis Echocardiography Pacemaker, Artificial Cardiac Patients
An extensive TTE protocol was carried out according to international guidelines (13 (link)) with additional focus on RV structure and function by acquiring 2D-MPE and 3D-TTE recordings. All TTEs were performed by sonographers specialised in congenital echocardiography. Studies were acquired using an EPIQ7 ultrasound system (Philips Medical Systems, Best, The Netherlands) equipped with an X5-1 matrix array transducer (composed of 3,040 elements with 1–5 MHz). Spatial and temporal resolution were optimised for 2D RV focused images in order to perform strain analysis offline. 3D recordings of the right heart were either multi-beat full volume acquisitions or made with single beat HeartModel software (Philips Medical Systems). Recordings were optimised to include the right ventricle at the highest possible volume rate with slight over gaining of the 2D image. Conventional 2D echocardiographic parameters for left and right heart size and function were collected in addition to the grading of any valvular lesions as either less than (<) or equal or greater than (≥) moderate in severity using parameters as documented in published guidelines (14 (link), 15 (link)). RV basal, mid and longitudinal linear dimensions alongside fractional area change (FAC) were measured in the standard focused RV apical four chamber view. Tricuspid annular plane systolic excursion (TAPSE) and tissue Doppler imaging derived tricuspid annular peak systolic velocity (RV-S') were measured at the basal RV lateral wall.
Publication 2023
2D Echocardiography Echocardiography Heart Strains Systole Tissues Transducers Ultrasonography Ventricles, Right
The evaluation of regional RV wall function by 2D multi-plane echocardiography has been well documented in our previous publications (12 (link), 16 (link)). In short, from a fixed apical probe position, electronic plane rotation around the RV apex allows visualisation of different RV free wall regions. Each RV wall is confirmed by the presence of a certain left-sided landmark associated with an approximate degree of electronic rotation. Throughout imaging, the RV should be non-foreshortened with the RV apex and interventricular septum centred along or as near to the midline of the imaging sector as possible. For this study, three views were utilised visualising the lateral, anterior and inferior RV wall regions. The first view at 0˚ shows the lateral RV wall with the left sided landmark being the mitral valve. The second view at approximately +40˚ shows the anterior RV wall and the coronary sinus and thirdly at approximately −40˚ the inferior RV wall and the aortic valve (Figure 1, Supplementary Videos S1–S3). The RV datasets were digitally exported to a vendor-neutral server (TomTec Imaging Systems, Unterschleissheim, Germany) and data analysis was performed offline by one experienced observer (DB). To assess peak systolic RV longitudinal strain, an RV algorithm wall motion tracking software was used (2D CPA, Image-Arena version 4.6; TomTec Imaging Systems). RV systole was determined as the time interval from electrocardiographic QRS onset to minimum RV cavity size, which was used as a surrogate for pulmonary valve closure. The endocardial borders of the RV free wall and septum were manually traced at end systole and adjusted accordingly in end diastole if required. This was performed in each of the other multi-plane views previously described. A single segment RV longitudinal strain (RV-LS) value for each wall was derived from the average of the basal, mid and apical segments. A measurement was considered feasible if all portions of the RV wall tracked acceptably throughout the cardiac cycle. If tracking was deemed inaccurate, the wall was excluded from analysis. The 3D datasets were digitally exported to the same TomTec server and analysed by DB using specialised RV analysis software (TomTec 4D-RV function 2.0). After placing set landmarks, RV volumes and ejection fraction (RVEF) were automatically calculated, with manual adjustment performed where necessary. In cases of inadequate tracking, the dataset was deemed unfeasible to measure and excluded from analysis.
Publication 2023
2D Echocardiography Dental Caries Diastole Echocardiography, Three-Dimensional Electrocardiography Endocardium Heart Mitral Valve Sinus, Coronary Strains Systole Valves, Aortic Valves, Pulmonary Ventricles, Right Ventricular Septum

Top products related to «2D Echocardiography»

Sourced in Canada, United States, Japan
The Vevo 2100 is a high-resolution, real-time in vivo imaging system designed for preclinical research. It utilizes advanced ultrasound technology to capture detailed images and data of small animal subjects.
Sourced in United States, Norway, United Kingdom, Japan, France, Canada, Germany, Belgium
The Vivid 7 is a high-performance ultrasound system designed for cardiovascular and general imaging applications. It features advanced imaging technologies and versatile capabilities to support comprehensive diagnostic assessments.
Sourced in United States, Norway, Japan, United Kingdom, Germany
The Vivid E9 is a diagnostic ultrasound system developed by GE Healthcare. It is designed to provide high-quality imaging for a wide range of clinical applications.
Sourced in Canada, United States
The Vevo 2100 Imaging System is a high-resolution ultrasound platform designed for preclinical research applications. It provides real-time, high-quality imaging of small animals and other biological samples.
Sourced in United States, Germany, Japan, Netherlands, Norway
The Sonos 5500 is a laboratory equipment designed for ultrasound imaging and analysis. It features a high-resolution display and advanced signal processing capabilities. The device is capable of generating and receiving ultrasound signals for a variety of applications in research and diagnostic settings.
Sourced in Canada, United States, Japan
The Vevo 770 is a high-resolution, real-time, in vivo micro-imaging system designed for small animal research. It employs high-frequency ultrasound technology to produce detailed anatomical and functional images.
Sourced in Norway, United States, United Kingdom
EchoPAC is a software application developed by GE Healthcare for the analysis and visualization of echocardiographic images. It provides tools for cardiac image management, measurement, and reporting.
Sourced in United States, Netherlands, Germany, Norway, United Kingdom
The EPIQ 7 is a high-performance ultrasound imaging system designed for a wide range of clinical applications. It features advanced imaging technologies and a user-friendly interface to provide clear and detailed images for diagnosis and treatment planning.
Sourced in Canada, United States
The Vevo 2100 system is a high-frequency, high-resolution micro-ultrasound imaging platform designed for preclinical research applications. The system utilizes advanced transducer technology to capture real-time, high-quality images and data from small animal models.
Sourced in United States, Norway, United Kingdom, Japan
The Vivid E95 is a high-performance cardiovascular ultrasound system designed for comprehensive cardiac and vascular imaging. It features advanced technologies and a user-friendly interface.

More about "2D Echocardiography"

2D echocardiography, also known as transthoracic echocardiography (TTE), is a non-invasive medical imaging technique that uses high-frequency sound waves (ultrasound) to create real-time, two-dimensional images of the heart's structure and function.
This diagnostic tool allows clinicians to evaluate cardiac anatomy, valve function, heart wall motion, and pumping ability, providing valuable information for the detection and management of various cardiovascular conditions. 2D echocardiography has become an indispensable tool in modern cardiology, with a wide range of applications.
It can be performed at the bedside or in a clinical setting, making it a versatile and accessible diagnostic procedure.
The technique is safe, radiation-free, and can be repeated as needed, allowing for continuous monitoring and assessment of a patient's heart health.
Advancements in echocardiographic technology, such as the Vevo 2100, Vivid 7, Vivid E9, Vevo 2100 Imaging System, Sonos 5500, Vevo 770, EchoPAC, EPIQ 7, and Vivid E95, have enhanced the quality and capabilities of 2D echocardiography.
These systems offer improved image resolution, faster acquisition times, and advanced post-processing features, enabling clinicians to make more informed decisions and deliver personalized treatment plans for their patients.
By incorporating the latest technological innovations and leveraging the power of artificial intelligence, PubCompare.ai can elevate 2D echocardiography research by optimizing protocols, identifying cutting-edge techniques from literature, preprints, and patents, and providing AI-driven comparisons to help researchers and clinicians identify the most effective protocols and products.